Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celine Vidaillac

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Review of Respiratory Medicine|March 19, 2021
<i>Pseudomonas aeruginosa</i> in bronchiectasis: infection, inflammation, and therapiesCeline Vidaillac, Sanjay H Chotirmall
Antimicrobial Agents and Chemotherapy|May 18, 2011
Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic modelMolly Steed, Celine Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy|February 16, 2011
Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro modelCeline Vidaillac, Molly E Steed, Michael J Rybak
Antimicrobial Agents and Chemotherapy|October 6, 2010
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetationsMolly E Steed, Celine Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy|August 2, 2017
<i>In Vitro</i> Evaluation of Biofilm Dispersal as a Therapeutic Strategy To Restore Antimicrobial EfficacyDan Roizman, Celine Vidaillac, Michael Givskov, et al.
International Journal of Antimicrobial Agents|July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolatesCeline Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolatesKimberly D Leuthner, Celine Vidaillac, Chrissy M Cheung, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Infectious Diseases and Therapy|December 19, 2014
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial BiofilmAshley D Hall Snyder, Celine Vidaillac, Warren Rose, et al.
Breathe (Sheffield, England)|June 8, 2018
Gender differences in bronchiectasis: a real issue?Celine Vidaillac, Valerie F L Yong, Tavleen K Jaggi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Respiratory Medicine|March 19, 2021
<i>Pseudomonas aeruginosa</i> in bronchiectasis: infection, inflammation, and therapiesCeline Vidaillac, Sanjay H Chotirmall
Antimicrobial Agents and Chemotherapy|May 18, 2011
Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic modelMolly Steed, Celine Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy|February 16, 2011
Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro modelCeline Vidaillac, Molly E Steed, Michael J Rybak
Antimicrobial Agents and Chemotherapy|October 6, 2010
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetationsMolly E Steed, Celine Vidaillac, Michael J Rybak
Antimicrobial Agents and Chemotherapy|August 2, 2017
<i>In Vitro</i> Evaluation of Biofilm Dispersal as a Therapeutic Strategy To Restore Antimicrobial EfficacyDan Roizman, Celine Vidaillac, Michael Givskov, et al.
International Journal of Antimicrobial Agents|July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolatesCeline Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolatesKimberly D Leuthner, Celine Vidaillac, Chrissy M Cheung, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Infectious Diseases and Therapy|December 19, 2014
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial BiofilmAshley D Hall Snyder, Celine Vidaillac, Warren Rose, et al.
Breathe (Sheffield, England)|June 8, 2018
Gender differences in bronchiectasis: a real issue?Celine Vidaillac, Valerie F L Yong, Tavleen K Jaggi, et al.
Pageof 3